Related Experiment Video
Updated: Nov 28, 2025

06:00
Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection
Published on: January 26, 2024
1.7K
Three-Dimensional Paper-Based Microfluidic Analysis Device for Simultaneous Detection of Multiple Biomarkers with a
Seung Ho Baek1, Chanyong Park2, Jaehyung Jeon1
1School of Mechanical Engineering, Sungkyunkwan University, Suwon 16419, Korea.
Biosensors
|November 25, 2020
Summary
This study introduces a 3D paper-based microfluidic analysis device (3D-μPAD) for simultaneous detection of multiple disease biomarkers. The 3D-μPAD platform enables smartphone-based analysis for point-of-care testing.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Point-of-Care Diagnostics
Background:
- Paper-based microfluidic analysis devices (μPADs) are cost-effective for diagnostics but often limited in multiplexing capabilities.
- Three-dimensional (3D)-μPADs offer improved performance, yet require development for simultaneous multi-biomarker detection for accurate disease diagnosis.
Purpose of the Study:
- To develop and demonstrate a 3D-μPAD platform for the simultaneous detection of multiple disease-related biomarkers.
- To enable analysis and diagnosis of these biomarkers using a smartphone-based application.
Main Methods:
- Fabrication of 3D-μPADs using 3D digital light processing printing.
- Design includes a sample reservoir connected to 24 detection zones via microchannels.
- Integration with a smartphone application for biomarker quantification.
Main Results:
- The platform successfully detected eight different biomarkers (glucose, cholesterol, albumin, alkaline phosphatase, creatinine, AST, ALT, urea nitrogen) across a range of clinically relevant concentrations.
- Detection ranges included normal to abnormal levels for each biomarker.
- Demonstrated simultaneous detection capability of multiple biomarkers.
Conclusions:
- The developed 3D-μPAD platform facilitates simultaneous multi-biomarker detection.
- This technology shows significant potential as a point-of-care testing (POCT) platform for comprehensive disease diagnosis.

